About inspire medical systems inc - INSP
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
INSP At a Glance
Inspire Medical Systems, Inc.
5500 Wayzata Boulevard
Golden Valley, Minnesota 55416
| Phone | 1-844-672-4357 | Revenue | 911.98M | |
| Industry | Medical Specialties | Net Income | 145.42M | |
| Sector | Health Technology | 2025 Sales Growth | 13.599% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,333 | |
| View SEC Filings |
INSP Valuation
| P/E Current | 11.252 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 18.873 |
| Price to Sales Ratio | 3.009 |
| Price to Book Ratio | 3.374 |
| Price to Cash Flow Ratio | 23.46 |
| Enterprise Value to EBITDA | 38.027 |
| Enterprise Value to Sales | 2.707 |
| Total Debt to Enterprise Value | 0.013 |
INSP Efficiency
| Revenue/Employee | 684,156.789 |
| Income Per Employee | 109,093.773 |
| Receivables Turnover | 7.619 |
| Total Asset Turnover | 1.056 |
INSP Liquidity
| Current Ratio | 6.076 |
| Quick Ratio | 4.564 |
| Cash Ratio | 3.209 |
INSP Profitability
| Gross Margin | 85.392 |
| Operating Margin | 5.587 |
| Pretax Margin | 7.204 |
| Net Margin | 15.946 |
| Return on Assets | 16.842 |
| Return on Equity | 19.774 |
| Return on Total Capital | 17.88 |
| Return on Invested Capital | 18.998 |
INSP Capital Structure
| Total Debt to Total Equity | 4.116 |
| Total Debt to Total Capital | 3.954 |
| Total Debt to Total Assets | 3.501 |
| Long-Term Debt to Equity | 3.84 |
| Long-Term Debt to Total Capital | 3.688 |